Patrick Mallon to Pandemics
This is a "connection" page, showing publications Patrick Mallon has written about Pandemics.
Connection Strength
0.062
-
COVID19- clinical presentation and therapeutic considerations. Biochem Biophys Res Commun. 2021 01 29; 538:125-131.
Score: 0.030
-
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 03; 21(1):758.
Score: 0.008
-
Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia. Eur Respir J. 2020 08; 56(2).
Score: 0.007
-
Prevalence of comorbid asthma in COVID-19 patients. J Allergy Clin Immunol. 2020 08; 146(2):334-335.
Score: 0.007
-
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 05 25; 21(1):430.
Score: 0.007
-
Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomes. AIDS. 2020 10 01; 34(12):1795-1800.
Score: 0.002